Milan, August 3, 2026. Clessidra Private Equity SGR, the private equity arm of the Clessidra Group—one of Italy’s leading alternative investment providers—announces the acquisition of a 70% stake in Errebi Technology S.p.A. through the Clessidra Capital Partners Green Harvest fund. Entrepreneur Massimiliano Paglione retains a 30% stake and is reinvesting alongside Clessidra. Androschin & Partner conducted the commercial due diligence for Clessidra Group Private Equity SGR.
TRANSACTION
·
November 2018
HANNOVER Finanz Acquires a Stake in ATEC Pharmatechnik GmbH
Hanover, late 2018. HANNOVER Finanz becomes a minority shareholder (49%) in ATEC Pharmatechnik GmbH; the founder reacquires a 51% stake through an acquisition vehicle (owner buyout) to secure the company’s succession. Androschin & Partner (A&P) advised on the transaction and conducted commercial due diligence on behalf of HANNOVER Finanz.
INVESTOR
Hannover Finanz
→
TARGET
ATEC Pharmatechnik GmbH
ABOUT THE COMPANY
ATEC Pharmatechnik GmbH
ATEC Pharmatechnik, founded in 1996 near Flensburg, is a leading global manufacturer of solutions for aseptic processing in pharmaceutical production (including stopper washing machines); its customers include the world's top ten pharmaceutical companies.
ABOUT THE INVESTOR
Hannover Finanz
Founded in 1979, the HANNOVER Finanz Group is an owner-managed equity partner for small and medium-sized enterprises, with offices in Hanover and Vienna.
OUR ROLE
Commercial Due Diligence